https://www.selleckchem.com/products/apcin.html
tonia (EU48695) and Karolinska Institute. Authors do not have any conflict of interest. We aimed to develop a gene expression-based prognostic signature for isocitrate dehydrogenase (IDH) wild-type glioblastoma using clinical trial datasets representative of glioblastoma clinical trial populations. Samples were collected from newly diagnosed patients with IDH wild-type glioblastoma in the ARTE, TAMIGA, EORTC 26101 (referred to as "ATE", AVAglio, and GLARIUS trials, or treated at UCLA. Transcriptional profiling was achieved with the NanoS
Like
Comment
Share
